CLIN EPIGENETICS - Clinical Epigenetics

Publications

  1. 2022
  2. First step towards a consensus strategy for multi-locus diagnostic testing of imprinting disorders

    Mackay, D., Bliek, J., Kagami, M., Tenorio-Castano, J., Pereda, A., Brioude, F., Netchine, I., Papingi, D., de Franco, E., Lever, M., Sillibourne, J., Lombardi, P., Gaston, V., Tauber, M., Diene, G., Bieth, E., Fernandez, L., Nevado, J., Tümer, Z., Riccio, A., Maher, E. R., Beygo, J., Tannorella, P., Russo, S., de Nanclares, G. P., Temple, I. K., Ogata, T., Lapunzina, P. & Eggermann, T., 07.11.2022, In: CLIN EPIGENETICS. 14, 1, 143.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2021
  4. DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status

    Jurmeister, P., Weber, K., Villegas, S., Karn, T., Untch, M., Thieme, A., Müller, V., Taube, E., Fasching, P., Schmitt, W. D., Marmé, F., Stickeler, E., Sinn, B. V., Jank, P., Schem, C., Klauschen, F., van Mackelenbergh, M., Denkert, C., Loibl, S. & Capper, D., 03.10.2021, In: CLIN EPIGENETICS. 13, 1, 184.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients

    Heinze, K., Rengsberger, M., Gajda, M., Jansen, L., Osmers, L., Oliveira-Ferrer, L., Schmalfeldt, B., Dürst, M., Häfner, N. & Runnebaum, I. B., 22.01.2021, In: CLIN EPIGENETICS. 13, 1, p. 15

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. 2019
  7. Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia

    van Tilburg, C. M., Milde, T., Witt, R., Ecker, J., Hielscher, T., Seitz, A., Schenk, J-P., Buhl, J. L., Riehl, D., Frühwald, M. C., Pekrun, A., Rossig, C., Wieland, R., Flotho, C., Kordes, U., Gruhn, B., Simon, T., Linderkamp, C., Sahm, F., Taylor, L., Freitag, A., Burhenne, J., Foerster, K. I., Meid, A. D., Pfister, S. M., Karapanagiotou-Schenkel, I. & Witt, O., 10.12.2019, In: CLIN EPIGENETICS. 11, 1, p. 188

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. Random forest-based modelling to detect biomarkers for prostate cancer progression

    Toth, R., Schiffmann, H., Hube-Magg, C., Büscheck, F., Höflmayer, D., Weidemann, S., Lebok, P., Fraune, C., Minner, S., Schlomm, T., Sauter, G., Plass, C., Assenov, Y., Simon, R., Meiners, J. & Gerhäuser, C., 22.10.2019, In: CLIN EPIGENETICS. 11, 1, p. 148

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. DNA methylation profiling allows for characterization of atrial and ventricular cardiac tissues and hiPSC-CMs

    Hoff, K., Lemme, M., Kahlert, A-K., Runde, K., Audain, E., Schuster, D., Scheewe, J., Attmann, T., Pickardt, T., Caliebe, A., Siebert, R., Kramer, H-H., Milting, H., Hansen, A., Ammerpohl, O. & Hitz, M-P., 11.06.2019, In: CLIN EPIGENETICS. 11, 1, p. 89

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. DNA methylation at an enhancer of the three prime repair exonuclease 2 gene (TREX2) is linked to gene expression and survival in laryngeal cancer

    Weigel, C., Chaisaingmongkol, J., Assenov, Y., Kuhmann, C., Winkler, V., Santi, I., Bogatyrova, O., Kaucher, S., Bermejo, J. L., Leung, S. Y., Chan, T. L., Lasitschka, F., Bohrer, M. H., Marx, A., Haußen, R. H., Herold-Mende, C., Dyckhoff, G., Boukamp, P., Delank, K. W., Hörmann, K., Lippert, B. M., Baier, G., Dietz, A., Oakes, C. C., Plass, C., Becher, H., Schmezer, P., Ramroth, H. & Popanda, O., 03.05.2019, In: CLIN EPIGENETICS. 11, 1, p. 67

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsiveness

    Kari, V., Raul, S. K., Henck, J. M., Kitz, J., Kramer, F., Kosinsky, R. L., Übelmesser, N., Mansour, W. Y., Eggert, J., Spitzner, M., Najafova, Z., Bastians, H., Grade, M., Gaedcke, J., Wegwitz, F. & Johnsen, S. A., 07.01.2019, In: CLIN EPIGENETICS. 11, 1, p. 4

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. 2015
  13. MicroRNA-100 and microRNA-21 as markers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II

    Dhayat, S. A., Abdeen, B., Köhler, G., Senninger, N., Haier, J. & Mardin, W. A., 2015, In: CLIN EPIGENETICS. 7, p. 132

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. 2014
  15. 11p15 DNA-methylation analysis in monozygotic twins with discordant intrauterine development due to severe twin-to-twin transfusion syndrome

    Schreiner, F., Gohlke, B., Stutte, S., Bartmann, P., Hecher, K., Oldenburg, J., El-Maarri, O. & Woelfle, J., 01.01.2014, In: CLIN EPIGENETICS. 6, p. 6

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. 2011
  17. Aberrant DNA hypermethylation of the ITIH5 tumor suppressor gene in acute myeloid leukemia.

    Oing, C., Jost, E., Dahl, E., Wilop, S., Brümmendorf, T. & Galm, O., 2011, In: CLIN EPIGENETICS. 2, 2, p. 419-423 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review